Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States.
J Org Chem. 2020 Jun 19;85(12):8214-8220. doi: 10.1021/acs.joc.0c00549. Epub 2020 Jun 9.
5-Cyanoimidazole was identified as an inexpensive ligand for nickel-catalyzed cross-electrophile couplings by screening a diverse set of pharmaceutical compound library. A strategic screening approach led to the discovery of this novel ligand, which was successfully applied in the preparation of various alkylated arene products with good to high yields. Furthermore, the properties of this ligand allowed expanding the scope of reductive couplings to challenging substrates, such as sterically hindered neopentyl halides, which are known to generate motifs that are prevalent in biologically active molecules.
5-氰基咪唑通过筛选多种药物化合物文库被鉴定为一种用于镍催化交叉电偶联反应的廉价配体。一种战略性的筛选方法导致了这种新型配体的发现,并成功地应用于制备各种烷基化芳烃产物,收率良好至高产率。此外,该配体的性质允许将还原偶联的范围扩展到具有挑战性的底物,如空间位阻的新戊基卤化物,这些卤化物通常会生成在生物活性分子中很常见的结构单元。